Agios Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
AGIO
CUSIP
00847X104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 254 68.6 M $2.52 B
2026 Q1 251 63.1 M $2.12 B
2025 Q4 261 61.3 M $1.67 B
2025 Q3 249 63.7 M $2.55 B
2025 Q2 228 62.3 M $2.07 B
2025 Q1 235 60.1 M $1.76 B
2024 Q4 240 59.8 M $1.97 B
2024 Q3 231 59.9 M $2.66 B
2024 Q2 226 60.8 M $2.62 B
2024 Q1 211 67.1 M $1.96 B
2023 Q4 189 63.8 M $1.42 B
2023 Q3 164 59.4 M $1.47 B
2023 Q2 168 59.4 M $1.68 B
2023 Q1 180 59.2 M $1.36 B
2022 Q4 179 62.7 M $1.76 B
2022 Q3 190 58.4 M $1.65 B
2022 Q2 172 59.2 M $1.31 B
2022 Q1 184 60.2 M $1.75 B
2021 Q4 183 59.4 M $1.95 B
2021 Q3 180 60.9 M $2.81 B
2021 Q2 205 65.9 M $3.63 B
2021 Q1 195 65.3 M $3.37 B
2020 Q4 234 65.6 M $2.84 B
2020 Q3 231 65.9 M $2.30 B
2020 Q2 240 67.9 M $3.63 B
2020 Q1 227 69.6 M $2.48 B
2019 Q4 226 70.0 M $3.34 B
2019 Q3 212 63.1 M $2.05 B
2019 Q2 214 61.3 M $3.06 B
2019 Q1 224 60.1 M $4.06 B
2018 Q4 218 58.6 M $2.70 B
2018 Q3 231 57.0 M $4.39 B
2018 Q2 238 54.9 M $4.63 B
2018 Q1 216 55.7 M $4.55 B
2017 Q4 193 47.0 M $2.69 B
2017 Q3 186 46.1 M $3.07 B
2017 Q2 183 46.2 M $2.37 B
2017 Q1 170 41.1 M $2.40 B
2016 Q4 177 39.1 M $1.63 B
2016 Q3 177 37.9 M $2.00 B
2016 Q2 167 34.1 M $1.43 B
2016 Q1 169 33.8 M $1.37 B
2015 Q4 161 33.2 M $2.15 B
2015 Q3 161 31.5 M $2.22 B
2015 Q2 170 30.1 M $3.35 B
2015 Q1 159 28.0 M $2.64 B
2014 Q4 155 27.7 M $3.10 B
2014 Q3 125 24.5 M $1.50 B
2014 Q2 105 24.9 M $1.14 B
2014 Q1 76 20.5 M $804 M